Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
暂无分享,去创建一个
Cynthia S Crowson | Eric L Matteson | S. Gabriel | E. Matteson | S. Achenbach | J. Ryu | C. Crowson | C. Nannini | Tim Bongartz | Carlotta Nannini | Yimy F Medina-Velasquez | Sara J Achenbach | Jay H Ryu | Robert Vassallo | Sherine E Gabriel | R. Vassallo | T. Bongartz | Yimy F. Medina-Velásquez
[1] M. Sugimoto,et al. Comparison of pulmonary abnormalities on high-resolution computed tomography in patients with early versus longstanding rheumatoid arthritis. , 2008, The Journal of rheumatology.
[2] D. Schwartz,et al. Rheumatoid arthritis lung disease. Determinants of radiographic and physiologic abnormalities. , 1996, Arthritis and rheumatism.
[3] S. Gabriel,et al. Cardiovascular death in rheumatoid arthritis: a population-based study. , 2005, Arthritis and rheumatism.
[4] P. Ellman,et al. “Rheumatoid Disease” with Joint and Pulmonary Manifestations , 1948, British medical journal.
[5] C. Turesson,et al. Extra-articular rheumatoid arthritis: prevalence and mortality. , 1999, Rheumatology.
[6] F. Arnett. Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.
[7] F. Wolfe,et al. The mortality of rheumatoid arthritis. , 1994, Arthritis and rheumatism.
[8] J. Dawson,et al. Fibrosing alveolitis in patients with rheumatoid arthritis as assessed by high resolution computed tomography, chest radiography, and pulmonary function tests , 2001, Thorax.
[9] W. Travis,et al. Progressive preclinical interstitial lung disease in rheumatoid arthritis. , 2008, Archives of internal medicine.
[10] J. Dawson,et al. Predictors of progression of HRCT diagnosed fibrosing alveolitis in patients with rheumatoid arthritis , 2002, Annals of the rheumatic diseases.
[11] S. Gabriel,et al. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. , 1999, Arthritis and rheumatism.
[12] L. Carmona,et al. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity , 2003, Annals of the rheumatic diseases.
[13] Paul J. Friedman,et al. American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Society (ERS) was adopted by the ATS board of directors , 2002, American journal of respiratory and critical care medicine.
[14] S. Gabriel,et al. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years , 2003, Annals of the rheumatic diseases.
[15] A. Nicholson,et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. , 2007, American journal of respiratory and critical care medicine.
[16] J. Rasker,et al. Outcome after 40 years with rheumatoid arthritis: a prospective study of function, disease activity, and mortality. , 2004, The Journal of rheumatology. Supplement.
[17] F. Granath,et al. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964-95. , 2002, The Journal of rheumatology.
[18] I. Broder,et al. The extra-articular features of rheumatoid arthritis. A systematic analysis of 127 cases. , 1973, The American journal of medicine.
[19] D. Symmons,et al. Longterm mortality outcome in patients with rheumatoid arthritis: early presenters continue to do well. , 1998, The Journal of rheumatology.
[20] S. R. Dahlqvist,et al. Cardiovascular morbidity and mortality in patients with seropositive rheumatoid arthritis in Northern Sweden. , 1997, The Journal of rheumatology.
[21] E. Kulinskaya,et al. Mortality in rheumatoid arthritis. Increased in the early course of disease, in ischaemic heart disease and in pulmonary fibrosis. , 2006, Rheumatology.
[22] E. Matteson,et al. Lung disease in rheumatoid arthritis , 2008, Current opinion in rheumatology.
[23] N. Goodson,et al. Cardiovascular admissions and mortality in an inception cohort of patients with rheumatoid arthritis with onset in the 1980s and 1990s , 2005, Annals of the rheumatic diseases.
[24] S. Gabriel,et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. , 2002, Arthritis and rheumatism.
[25] S. Gabriel,et al. Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[26] O. Steinbrocker,et al. Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.
[27] L. Melton,et al. History of the Rochester Epidemiology Project. , 1996, Mayo Clinic proceedings.
[28] M. Liang,et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.
[29] R. Balk,et al. The relationship of preexisting lung disease to the development of methotrexate pneumonitis in patients with rheumatoid arthritis. , 1995, The Journal of rheumatology.
[30] S. Gabriel,et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. , 2002, The Journal of rheumatology.
[31] E. Gabbay,et al. Interstitial lung disease in recent onset rheumatoid arthritis. , 1997, American journal of respiratory and critical care medicine.
[32] C. Kelly,et al. Interstitial lung disease in patients with rheumatoid arthritis: comparison with cryptogenic fibrosing alveolitis over 5 years. , 2006, The Journal of rheumatology.
[33] S. Lane,et al. Clinical expression of leflunomide-induced pneumonitis. , 2009, Rheumatology.
[34] S. Gabriel,et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. , 2003, Arthritis and rheumatism.